Search Results Search Sort by RelevanceMost Recent State of the Art and Science Mar 2021 Piloting and Scaling a Good Health Equity Evidence Base From Big Data Stephen Lockhart, MD, PhD One health system’s development and validation of inequity measures across patient groups demonstrates an approach that could be nationally scalable. AMA J Ethics. 2021;23(3):E252-257. doi: 10.1001/amajethics.2021.252. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Medical Education Jun 2017 Avoiding Racial Essentialism in Medical Science Curricula Lundy Braun, PhD and Barry Saunders, MD, PhD Medical education must acknowledge the problematic use of race as a biological or epidemiological risk factor in research and the controversy over race. AMA J Ethics. 2017;19(6):518-527. doi: 10.1001/journalofethics.2017.19.6.peer1-1706.
State of the Art and Science Mar 2021 Piloting and Scaling a Good Health Equity Evidence Base From Big Data Stephen Lockhart, MD, PhD One health system’s development and validation of inequity measures across patient groups demonstrates an approach that could be nationally scalable. AMA J Ethics. 2021;23(3):E252-257. doi: 10.1001/amajethics.2021.252.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Medical Education Jun 2017 Avoiding Racial Essentialism in Medical Science Curricula Lundy Braun, PhD and Barry Saunders, MD, PhD Medical education must acknowledge the problematic use of race as a biological or epidemiological risk factor in research and the controversy over race. AMA J Ethics. 2017;19(6):518-527. doi: 10.1001/journalofethics.2017.19.6.peer1-1706.